“…Due partly, if not entirely, to the secondary vaccine failure, the numbers of measles cases among adolescents (10 to 19 years old) and adults (20 to 39 years old) in Japan increased 1.7 times and 2.3 times, respectively, in 2001 over the previous year (10). Also, the latest studies have demonstrated the heterogeneous nature of MV, such as variations in hemagglutination (HA) activities (23,28) and electrophoretic mobility (21) of the H protein, variations in reactivity to monoclonal antibody (13), and nucleotide sequence diversity (11,25,26,34) between vaccine strains and currently circulating field strains. It is necessary, therefore, to compare the viral immunogenicity to humans between the two types of viruses and evaluate the protective efficacy of vaccine strains against currently circulating MV strains.…”